Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26
about
The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell deathEvi-1 transforming and repressor activities are mediated by CtBP co-repressor proteinsInteraction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear specklesIntergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain familyUXT interacts with the transcriptional repressor protein EVI1 and suppresses cell transformationSKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cellsOncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expressionGeneration of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemiaMeis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 miceEVI1 promotes cell proliferation by interacting with BRG1 and blocking the repression of BRG1 on E2F1 activityThe leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylaseTranscriptional repression mediated by the PR domain zinc finger gene RIZIdentification of binding sites of EVI1 in mammalian cellsZinc fingers 1-7 of EVI1 fail to bind to the GATA motif by itself but require the core site GACAAGATA for bindingThe retinoblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoterA novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9aAcute myeloid leukemia presenting with panhypopituitarism or diabetes insipidus: a case series with molecular genetic analysis and review of the literature.Diabetes insipidus revealing acute myelogenous leukaemia with a high platelet count, monosomy 7 and abnormalities of chromosome 3: a new entity?Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes.PRDM Proteins: Molecular Mechanisms in Signal Transduction and Transcriptional Regulation.Retroviral insertions in Evi12, a novel common virus integration site upstream of Tra1/Grp94, frequently coincide with insertions in the gene encoding the peripheral cannabinoid receptor Cnr2.Acetylation of lysine 564 adjacent to the C-terminal binding protein-binding motif in EVI1 is crucial for transcriptional activation of GATA2.Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells.Rearrangements of chromosome band 3q21 in myeloid leukemia.Tracking of specific integrant clones in dogs treated with foamy virus vectors.EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cellsA rapid RT-PCR based method to isolate complementary DNA fragments flanking retrovirus integration sites.Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocationsTranslocation t(2;3)(p15-23;q26-27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features.Molecular mechanisms of leukemogenesis by AML1/EVI-1.Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cellsSox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR.EVI1 acts as an inducible negative-feedback regulator of NF-κB by inhibiting p65 acetylation.Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization.Expression of the zinc finger gene EVI-1 in ovarian and other cancers.Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in miceLoss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming genemiR-133 regulates Evi1 expression in AML cells as a potential therapeutic targetFrom hematopoiesis to neuropoiesis: evidence of overlapping genetic programsDual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias.
P2860
Q22254262-9011AFAD-2CAE-4D0B-9DC9-3F86AFC53CDCQ24291175-96369090-8820-45B2-98B3-308DD0F2A6DDQ24291719-B8EFC13D-FA73-41FF-A0D9-2A1C59456B1CQ24314719-70609DCC-402F-478D-BED3-ABBA39983FD1Q24319893-050B27F8-5590-4D7E-B1BE-E2816224D51AQ24320328-85EED907-6E21-4F43-AE32-459D8CB94EC4Q24529138-3FFD9299-6D47-4466-AAC7-FDACB9F8F721Q24596770-CBA0450A-3CBA-44A7-AC6B-B4DAA14D7EF5Q24651171-3D1E4CAE-ACDB-4C45-9345-97F1738BFC97Q28209175-4CA5D2C7-174E-42F2-A505-2E3179D87339Q28216000-98E54686-A19A-4B91-B4B2-F2B5F52FD826Q28251530-56613815-C12F-4631-B457-257BBCCFFBB7Q28260755-FAAA29BE-C0A8-4C79-BAED-A9442A3D90EDQ28273005-CA3D399C-1CD5-455E-929A-4EE970C90904Q28302030-71513027-48BB-4954-9BC4-3976147D25D1Q28509961-6D661369-E1F9-4790-89D1-47CAC6788539Q30703420-5ADC9273-EC8E-4052-9F31-F577DC175BF8Q31899883-D8EF918C-401B-46C6-ADF9-21710739D9CAQ33270804-9016C553-E8DE-48F6-A3F2-69EBE79F01C5Q33565484-DF0DC35A-0911-4D3C-9AF9-5B9C8582D68CQ33646004-19E2B80F-CEB3-43F3-A575-F2D283811BA4Q33883148-B8EC00BC-7719-4B75-B1F6-C9D26771F634Q34288682-0FC47FA0-67C7-4EEE-BAD0-0DCB3DDE0927Q34573985-C3606D9D-1587-4A8D-A85D-34BE865A303CQ34589239-5E80EECA-2496-4C3F-9BC0-2C5F8A336030Q34606698-10A3DA09-BA0C-4E96-9EBA-752175F8E81EQ34640225-38C7446F-BB2B-4E38-918A-8E17E9C9BEF2Q35210567-C014EE59-E2A0-4862-B0F2-2227E194D562Q35746083-85AF92F4-23D0-406D-89F4-E0B1A906AEBFQ35779715-372CACE6-0E79-45E4-BAF7-3CB88AB19AE5Q35847760-F8E7C9E2-9C9B-493A-B2EB-453A4424D9C8Q35849315-B7B6E2B9-15FF-4658-8AF3-203AF0F265E3Q36016473-14CD68A4-925B-4357-8946-16C822F04121Q36018621-9AD5A183-0227-46FE-AD18-2B7400C3AB9EQ36136599-82BC39B1-E5DD-4F51-8ACD-CA23A2972DB6Q36151656-BBE0DF76-13AE-4262-9C72-89C398D459F0Q36413795-8474FCF4-DEB4-420B-A287-8B7034C2A30FQ36453826-66DE1DEE-125E-4227-AB7B-65862796E8B3Q36531326-A075CBF4-11F6-4130-847E-83B185EAB54CQ36550719-00CFC130-F334-480B-BBA7-3D47D07F0A1D
P2860
Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26
description
1992 nî lūn-bûn
@nan
1992 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Activation of EVI1 gene expres ...... obases on chromosome band 3q26
@ast
Activation of EVI1 gene expres ...... obases on chromosome band 3q26
@en
Activation of EVI1 gene expres ...... obases on chromosome band 3q26
@nl
type
label
Activation of EVI1 gene expres ...... obases on chromosome band 3q26
@ast
Activation of EVI1 gene expres ...... obases on chromosome band 3q26
@en
Activation of EVI1 gene expres ...... obases on chromosome band 3q26
@nl
prefLabel
Activation of EVI1 gene expres ...... obases on chromosome band 3q26
@ast
Activation of EVI1 gene expres ...... obases on chromosome band 3q26
@en
Activation of EVI1 gene expres ...... obases on chromosome band 3q26
@nl
P2093
P2860
P356
P1476
Activation of EVI1 gene expres ...... obases on chromosome band 3q26
@en
P2093
C L William
E Parganas
K Morishita
M B Valentine
M H Whittaker
P2860
P304
P356
10.1073/PNAS.89.9.3937
P407
P577
1992-05-01T00:00:00Z